Characteristic | Number (%) N = 96 |
---|---|
Comparison with derivation cohort | |
 Mention of differences (or no difference) in definitions between the validation and the derivation cohort for each of the following | |
  Setting | 17 (17.7) |
  Eligibility criteria | 21 (21.9) |
  Predictors | 21 (21.9) |
  Outcome | 21 (21.9) |
  Unclear or not reported | 71 (74.0) |
 Mention of differences (or no difference) in definitions between the validation and the derivation cohort | |
  Mentioned all four (setting, eligibility, predictors, outcome) | 17 (17.7) |
  Some are mentioned | 8 (8.3) |
  Unclear or not reported | 71 (74.0) |
 Distribution of important variables (demographics [at least age and sex], predictors, and outcome) presented along with the development study | |
  Yes | 21 (21.9) |
Model evaluation | |
 Type of external validation | |
  Temporal | 4 (4.2) |
  Geographical | 64 (66.7) |
  Methodological/setting (different setting such as ED vs clinic) | 26 (27.1) |
  Unclear or not reported | 2 (2.1) |
 Model adjusted or updated | |
 Yes | 23 (24.0) |